Cannabis Law Report

FEBRUARY 18, 2022

We are one of the first to successfully complete a commercial shipment of Colombian-manufactured high-CBD pharmaceutical product to Germany available for patients in pharmacies under prescription. In addition, this reflects our increasing know-how to comply with complex and sophisticated regulatory and quality frameworks.

Extraction 52

Extraction Pharmaceutical Patients Cannabinoids 52

Cannabis Law Report

JUNE 5, 2019

Press Release: Thailand Government Pharmaceutical Organization. The Pharmaceutical Organization, Department of Medical Affairs, signed a joint research on standard quality medical marijuana extracts for patients with chemo-allergic cancer, epilepsy, muscle contraction in patients with deteriorating nerve sheaths. 30 May 2019.

Pharmaceutical 40

Pharmaceutical Extraction Epilepsy Research and Development 40

Cannabis Law Report

NOVEMBER 3, 2021

This is a strategic opportunity for us to reach the widest audience of customers possible while being the first and, at the moment, the only company with a permit to market cannabis extracts for inhalation in Germany specifically and in Europe in general.

Extraction 52

Extraction Pharmaceutical Patients Treatment 52

Cannabis Info

MARCH 2, 2019

Marijuana as a treatment for epilepsy. Medical cannabis is showing great potential in the treatment of epilepsy. CONVENTIONAL TREATMENT. One of the goals of treating epilepsy is to allow people to continue to live functional and fulfilling life’s epilepsy treatment. CANNABIS AS A POTENTIAL TREATMENT.

Epilepsy 69

Epilepsy Treatment Marijuana Research and Development 69

Cannabis Law Report

OCTOBER 15, 2021

(USOTC: PAOG) cited a British Medical Journal case study report published today on the effectiveness of CBD in the treatment of lung cancer and COPD as validation of PAOG’s ongoing research and development of its own respiratory disorder treatment under the name RespRx. 9,199,960). 9,199,960).

Treatment 52

Treatment Research and Development CBD eCommerce 52

Cannabis Law Report

NOVEMBER 12, 2021

Ethypharm has signed an exclusive license agreement with Clever Leaves for the distribution of medical cannabis extracts in Germany, the most important European market for medical cannabis. Clever Leaves will manufacture and supply EU GMP certified medical cannabis extracts sourced from their facilities in Colombia and Portugal.

Extraction 52

Extraction Chronic Pain Pharmaceutical THC 52

Cannabis Law Report

JANUARY 16, 2020

(“Devonian” or the “Corporation”) (TSXv:GSD), a clinical stage botanical pharmaceutical corporation, focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical products, announced today the signature of a lease Agreement with Hzb Pharma Canada Inc. Tweet this.

Extraction 64

Extraction Pharmaceutical Research and Development Terpenes 64

Project CBD

NOVEMBER 11, 2023

In general, I think that botanical medicine is safer than pharmaceutical medicine, that the chances of causing harm are much less. And then cannabis has unique effects for a wide range of conditions, everything from the treatment of pain, treatment of asthma, treatment of immune conditions.

Medicine 301

Medicine Research and Development Pharmaceutical Cannabis 301

WeedAdvisor

JANUARY 8, 2019

For decades, marijuana for cancer treatment seemed out of the question. Even if trials were successful, it is safe to say that using marijuana to treat cancer would meet resistance from the pharmaceutical companies and medical communities alike. The Endocannabinoid System in Cannabis Cancer Treatment.

Treatment 75

Treatment Research and Development Cannabinoids THC 75

Cannabis Law Report

NOVEMBER 22, 2019

Nextleaf Solutions Ltd ( CSE:OILS ) (OTCMKTS:OILFF) has been awarded two patents related to extraction of THC and CBD, bringing its total issued patents to ten. READ: Nextleaf Solutions says its distillation plant on pace to be completed by end of this month. ”

Extraction 59

Extraction Cannabinoids Oil Pharmaceutical 59

The Cannigma

FEBRUARY 1, 2023

His team is using novel techniques aimed at untangling the complex interactions between specific plant extracts with cancer cancer cells. 7 The use of cannabis as a cancer treatment was popularized by Rick Simpson, a medical cannabis advocate. GBM is a rare but aggressive brain cancer with very limited treatment options.

Clinical Trials 145

Clinical Trials Research and Development Therapy Cannabinoids 145

Cannabis Chronicles

APRIL 2, 2019

People have been drawn to the extract because of its supposed calming effects. It also said any products that make drug or treatment claims also need to be approved by the FDA. The FDA has approved a pharmaceutical version of CBD to treat rare seizure disorders. NEW YORK — U.S.

CBD 113

CBD Food Pharmaceutical Collective 113

Cannabis Law Report

JUNE 28, 2021

Pharmaceutical and Medical Cannabis Leaders Zambon GmbH and Adven GmbH will Drive Medical Cannabis Supporting Treatments for Neurological Therapies. The aim of the agreement is to make medical cannabis treatments available to patients, with an initial focus on neurological therapies. The market for medical cannabis in Germany.

Access 105

Access Research and Development Pharmaceutical Therapy 105

The Joint Blog

NOVEMBER 2, 2020

According to a new study published in the Journal of Pharmacy & Pharmaceutical Sciences, using marijuana as an adjunct treatment for Huntington disease (HD) is both effective and safe. Study selection, quality assessment and data extraction was performed by three reviewers.

Treatment 37

Treatment Sleep Marijuana Patients 37

Cannabis Info

OCTOBER 11, 2019

Cannabis & Dementia: New Study Explores Pot’s Potential for Treatment. In the decades since the medical marijuana movement began in earnest in the 1970s, cannabis has been anecdotally touted as an effective treatment for a variety of illnesses, including those impacting brain function, such as seizures, anxiety and depression.

Treatment 45

Treatment Clinical Trials Cannabinoids Cannabis 45

Canna Care Docs

OCTOBER 3, 2023

Conventional medication methods such as opiates may help terminal patients focus on more palliative treatment options and goals in order to better one’s comfort and overall quality of life during this time. However, many of these pharmaceutical medications can just induce more unpleasant, debilitating effects on those who are ill.

Chronic Pain 105

Chronic Pain Clinical Trials Patients Cannabinoids 105

Cannabis Law Report

JANUARY 16, 2022

Malaysia’s National Pharmaceutical Regulatory Agency (NPRA) previously approved a prescription medicine derived from cannabis in 2014 to treat muscle spasms and spasticity from multiple sclerosis. Sativex was developed by GW Pharmaceuticals, a maker of cannabinoid therapeutics based in Ireland.

Research and Development 98

Research and Development Pharmaceutical Epilepsy Medicine 98

Green Relief

MARCH 25, 2018

An extremely interesting study (Overcoming the Bell-Shaped Dose-Response of Cannabidiol by using Cannabis Extract Enriched in Cannabidiol) was just published out of the Lautenberg Center for General and Tumor Immunology in Jerusalem. Materials Used: Plants, Animals, and Extracts. The purified CBD was acquired from THC Pharm.

Extraction 41

Extraction CBD Cannabinoids Strains 41

MMJ Recs

APRIL 1, 2024

We’re exploring the world of CBD, uncovering the benefits of CBD in medical marijuana, its impact on health, its potential as a treatment option, and what you need to know about its use in medical marijuana. CBD: A Promising Treatment Option One of the most compelling aspects of CBD is its versatility as a treatment option.

CBD 52

CBD Clinical Trials Chronic Pain Epilepsy 52

Cannabis Law Report

AUGUST 6, 2021

It’s well known that CBD can be very useful in the treatment of mental health disorders, such as anxiety and depression. When you’re buying CBD to treat your seizures, you need to make sure that you buy pure CBD extract. A lot of people are not comfortable with taking pharmaceutical medication. Anti-seizure Properties.

CBD 105

CBD Wellness and Beauty Treatment Pharmaceutical 105

FloridaMarijuana.net

AUGUST 16, 2018

The Dementia Society of America attributes Dementia to rising healthcare costs as billions are spent each year for treatments and research. Pharmaceutical treatments for for Dementia often only target symptoms like pain or depression, but those medicines do not cure or prevent the disease. 9-tetrahydrocannabinol (?9-THC)

Clinical Trials 184

Clinical Trials Marijuana Patients Pharmaceutical 184

Veriheal

AUGUST 9, 2023

This new research has increased our hopes for an alternate CBD source, which may increase the availability of CBD-based products, reduce purchase costs, and guarantee THC-free extracts. Even more, CBD is the first FDA-approved pharmaceutical drug for two rare forms of epileptic seizures in kids.

CBD 93

CBD Cannabinoids THC Extraction 93

Canna Law Blog

NOVEMBER 14, 2021

The application originally included goods in Class 5, namely, “Medical preparations for the treatment of PTSD, addiction, depression and mental disorders; Pharmaceutical preparations for the treatment of PTSD, addiction, depression and mental disorders.” Cybin (CLXPF).

Pharmaceutical 73

Pharmaceutical Treatment Edibles Medicine 73

United Patients Group

APRIL 18, 2023

Because they often combine it with other drugs like cocaine or heroin or even legal ‘prescribed’ pharmaceuticals–and those are far more dangerous than cannabis itself! The same cannot be said for alcohol or even caffeine (a more dangerous drug), which can lead to death if consumed excessively enough over time.

Research and Development 110

Research and Development Indica Treatment Conditions 110

Cannabis Law Report

AUGUST 9, 2021

The company’s innovative technology enables the provision of an exact amount of active ingredients through oral ingestion, using a high concentration of cannabinoids or medical cannabis extract in a homogeneous, uniform and stable formulation which can be administered in the form of oral capsules, syrups or buccal sprays. Of Cannassure.

Cannabinoids 98

Cannabinoids Pharmaceutical Treatment Patients 98

Cannabis Law Report

JUNE 2, 2021

and has no accepted medical use in treatment in the United States or lacks accepted safety for use in treatment under medical supervision.” Pharmaceutical Grade CBD Oil. Epidiolex is a Schedule V controlled substance approved for the treatment of seizures. Idaho Code § 37-2701 et seq. Idaho Code § 37-2704. Conclusion.

Law 103

Law Marijuana Oil Pharmaceutical 103

Cannabis Law Report

JANUARY 14, 2022

Unapproved medications such as cannabis in Germany can only be approved on the basis of three criteria: (1) When it is for the treatment of a serious (life-threatening or permanently detrimental to the quality of life) medical condition; (2) Where no other therapy is available; and. (3) Canopy sold the company for a maximum of €122.6

Pharmaceutical 52

Pharmaceutical Extraction Oil Patients 52

Cannabis Law Report

OCTOBER 10, 2019

In the Australian clinical study, cannabinoids will be extracted and delivered in a mouth spray, making it easier to be administered to the elderly. The spray will be produced by MGC Pharmaceuticals, an Australian firm founded by Israeli researchers. The clinical trial will be held over a 14-month period starting early next year.

Treatment 40

Treatment Clinical Trials Sleep Pharmaceutical 40

TheAnswerPage

MAY 20, 2022

The oromucosal spray Sativex (nabiximols) is a cannabis extract that contains the principal cannabinoids delta-9-tetrahydrocannibinol (THC) and cannabidiol (CBD) in a 50:50 ratio, as well as specific minor cannabinoids and other non-cannabinoid components. GW Pharmaceuticals website. See the Answer.

Nerve Pain 52

Nerve Pain Epilepsy Pharmaceutical Cannabinoids 52

Cannabis Law Report

JULY 27, 2021

NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, and Biopharmaceutical Research Company (“BRC”), a specialty pharmaceutical company that holds federal licenses for importing, analyzing and manufacturing controlled substances in the U.S.,

Research and Development 98

Research and Development Pharmaceutical Sativa Extraction 98

Cannabis Law Report

OCTOBER 22, 2021

The drug is currently in phase III stage of development for the treatment of spasticity in patients with multiple sclerosis not showing sufficient response to their current anti-spasticity treatment. Cannabis oil: TO Pharmaceuticals TO Pharma is developing next-generation cannabinoid therapies for debilitating diseases.

Research and Development 52

Research and Development Pharmaceutical Marijuana Chronic Pain 52

Veriheal

FEBRUARY 1, 2022

The team of researchers’ objective was to assess the effect of medical cannabis on patients with dystonia since it was suggested as a treatment for involuntary contractions of muscles in several case reports and case series. cannabidiol (CBD) , with participants having reported the use of cannabis oil extract, smoking dried cannabis, or both.

Treatment 98

Treatment Patients Cannabis Oil 98

Kind Meds (Cannabis Education Blog)

JANUARY 27, 2022

Since the popularization of CBD in recent years, it’s more common to see cannabis recognized as a true medical treatment. For instance, it might be a beneficial treatment for mood and anxiety disorders, such as depression or generalized anxiety. What Is CBN Extraction? CBN as a Sleep Aid and Insomnia Treatment.

Cannabinoids 52

Cannabinoids Treatment Extraction THC 52

Cannabis Law Report

MAY 29, 2019

The research will focus on the optimisation of breeding and cultivating processes and the extraction of material to assess their efficacy of medical cannabis on prostate, melanoma and other cancer cells. Here’s the press release. All intellectual property from the trials will be owned by MGC, which is funding the research.

Cultivation 40

Cultivation Pharmaceutical Clinical Trials Extraction 40

TheAnswerPage

AUGUST 19, 2021

The oromucosal spray Sativex (nabiximols) is a cannabis extract that contains the principal cannabinoids delta-9-tetrahydrocannibinol (THC) and cannabidiol (CBD) in a 50:50 ratio, as well as specific minor cannabinoids and other non-cannabinoid components. GW Pharmaceuticals website. See the Answer.

Nerve Pain 52

Nerve Pain Epilepsy Pharmaceutical Cannabinoids 52

TheAnswerPage

JUNE 14, 2021

The oromucosal spray Sativex (nabiximols) is a cannabis extract that contains the principal cannabinoids delta-9-tetrahydrocannibinol (THC) and cannabidiol (CBD) in a 50:50 ratio, as well as specific minor cannabinoids and other non-cannabinoid components. ” GW Pharmaceuticals website. ” GW Pharmaceuticals website.

Nerve Pain 52

Nerve Pain Epilepsy Pharmaceutical Cannabinoids 52

FloridaMarijuana.net

AUGUST 15, 2018

More than ever, cannabis can aid in the treatment of chronic disease and as a supplement to other medical interventions and treatments. While traditional pharmaceuticals may alleviate some of the associated symptoms, medical cannabis can aid even further, where pharma leaves off. Antispasmodic. Anticonvulsant/Seizures.

Chronic Pain 150

Chronic Pain Marijuana Patients Clinical Trials 150